GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BerGenBio ASA (FRA:7BG0) » Definitions » Unearned Premiums

BerGenBio ASA (FRA:7BG0) Unearned Premiums


View and export this data going back to 2019. Start your Free Trial

What is BerGenBio ASA Unearned Premiums?

Unearned Premiums only applies to insurance companies.


BerGenBio ASA Business Description

Traded in Other Exchanges
Address
Mollendalsbakken 9, Bergen, NOR, 5009
BerGenBio ASA is a clinical-stage biopharmaceutical Company focused on developing novel medicines for aggressive diseases. The company's clinical asset, bemcentinib, targeting the receptor tyrosine kinase AXL, is currently in development in a Ph1b/2a study in 1L STK 11 mutated NSCLC and preclinical development for severe respiratory infections.